Mimedx (MDXG) Net Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -198.00 |
| Dec 31, 2024 | 1,779.00 |
| Sep 30, 2024 | -456.00 |
| Jun 30, 2024 | 4,573.00 |
| Mar 31, 2024 | 3,064.00 |
| Dec 31, 2023 | 9,075.00 |
| Sep 30, 2023 | 886.00 |
| Jun 30, 2023 | 737.00 |
| Mar 31, 2023 | -1,055.00 |
| Dec 31, 2022 | 27.00 |
| Sep 30, 2022 | -3,107.00 |
| Jun 30, 2022 | -2,624.00 |
| Mar 31, 2022 | -2,888.00 |
| Dec 31, 2021 | 598.00 |
| Sep 30, 2021 | -1,136.00 |
| Jun 30, 2021 | -825.00 |
| Mar 31, 2021 | -1,867.00 |
| Dec 31, 2020 | -5,215.00 |
| Sep 30, 2020 | -9,420.00 |
| Jun 30, 2020 | -2,767.00 |
| Mar 31, 2020 | -1,783.00 |
| Dec 31, 2019 | -1,947.00 |
| Sep 30, 2019 | 289.00 |
| Jun 30, 2019 | -2,400.00 |
| Mar 31, 2019 | -1,523.00 |
| Dec 31, 2018 | -3,119.00 |
| Sep 30, 2018 | 170.00 |
| Jun 30, 2018 | 749.00 |
| Mar 31, 2018 | 1,951.00 |
| Dec 31, 2017 | 2,595.00 |
| Sep 30, 2017 | 6,921.00 |
| Jun 30, 2017 | 2,279.00 |
| Mar 31, 2017 | 3,788.00 |
| Dec 31, 2016 | 8,906.00 |
| Sep 30, 2016 | 8,720.00 |
| Jun 30, 2016 | 13,320.00 |
| Mar 31, 2016 | 32,305.00 |